The biotransformation of brassilexin, a potent phytoalexin produced by brown mustard (Brassica juncea L.), in the presence of various cruciferous phytoalexins was investigated. An important group of isolates of the fungal species Leptosphaeria maculans (Laird 2 and Mayfair 2), which is virulent to brown mustard, but not to canola, was used in this investigation. Brassilexin was detoxified by the fungus, but none of the phytoalexins seemed to affect substantially the rate of brassilexin detoxification; after 12 h of incubation, the amounts of brassilexin remaining in culture were as low as in controls, except in co-incubations with cyclobrassinin and sinalexin, which afforded intermediates that in solution oxidized spontaneously to brassilexin.
Cruciferous plants are cultivated worldwide due to their broad utilization and easy adaptation to very diverse environmental conditions. Crucifers provide a great variety of economically important crops that include sources of edible and industrial oils such as rapeseed, canola and mustard, widely consumed vegetables as for example cabbage, broccoli, rutabaga and turnip, and condiments like horseradish and wasabi. Many of these crops are susceptible to a number of fungal pathogens, including the devastating blackleg fungi [1] . Since the 1950s, fungal plant pathogens have been partly controlled by the use of general fungicides, but these practices are not environmentally sustainable. For these reasons, the discovery of novel strategies that prevent crop losses due to fungal diseases is of vital importance.
Phytoalexins are antimicrobial metabolites produced de novo by plants in response to pathogen attack and other stresses [2] . Crucifers (family Brassicaceae) produce phytoalexin mixtures whose composition depends not only on the particular cultivar/species but also on the type of stress [3] . Although each cruciferous species produces different phytoalexins, a common set of related phytoalexins is usually found within the genus Brassica [3] . Cruciferous phytoalexins display selective antifungal activities against different plant fungal pathogens.
The metabolism of cruciferous phytoalexins by fungal pathogens to compounds of much lower antifungal activity occurs in infected plants [4] . The outcome of these detoxification reactions is the quick depletion of a plant's natural defenses. Detoxification of cruciferous phytoalexins has been shown to occur either via degradation (oxidation, reduction or hydrolysis) or conjugation. These reactions are catalyzed by various enzymes that are produced by the particular fungal species. For example, degradation of brassinin (1) to indole-3-carboxaldehyde (2) is mediated by brassinin oxidase, which is only produced by isolates of L. maculans virulent on canola [5] . Hydrolysis of brassinin (1) to indolyl-3-methanamine (4) is mediated by brassinin hydrolase [6] , an enzyme produced by isolates of L. maculans virulent on brown mustard. By contrast, detoxification of brassinin (1) via conjugation with β-Dglucopyranose is mediated by brassinin glucosyl transferase, produced by Sclerotinia sclerotiorum (Lib.) de Bary (Scheme 1) [ 7, 8] . S. sclerotiorum is a plant pathogen with a very broad host range that detoxifies several cruciferous phytoalexins via conjugation with β-D-glucopyranose. Importantly, neither L. maculans virulent on canola nor L. maculans virulent on brown mustard could metabolize N′-methylbrassinin (5), a designer phytoalexin, that is, a synthetic analogue of brassinin (1) with higher antifungal activity than brassinin.
Currently, phytoalexin detoxification inhibitors (paldoxins) are being designed, synthesized and screened to establish if these compounds are able to protect cruciferous crops against specific fungal pathogens [3, 4, 9] . Unexpectedly, during these studies we discovered that some phytoalexins are natural inhibitors of fungal detoxifying enzymes. This discovery suggested that phytoalexins have different roles in protecting plants against fungi, as they inhibit both mycelial growth and specific enzymes. With these observations in mind, we set out to evaluate the transformation of the phytoalexin brassilexin (6), a phytoalexin produced by brown mustard (Brassica juncea L.), on its own and in the presence of other phytoalexins. An important group of isolates of L. maculans (Laird 2 and Mayfair 2, here on L2/M2), virulent to brown mustard but not to canola, was used in this investigation.
To determine the kinetics and potential products of brassilexin (6) transformation by L2/M2 isolates, cultures were incubated with this phytoalexin. In addition, to determine the effects of other phytoalexins on the detoxification rate of brassilexin, cultures were co-incubated with brassilexin (6) and one of the following phytoalexins: sinalexin (7) , cyclobrassinin (8), spirobrassinin (9), 1-methoxyspirobrassinin (10), dioxibrassinin (11) , brassicanate A (12), and camalexin (13) . Potential metabolism of phytoalexins was monitored by HPLC-DAD. Known metabolites were identified by direct comparison of their UV spectra and retention times with those of authentic samples available in our library of cruciferous metabolites. To date, only the transformations of brassinin (1) and indolyl-3-acetonitrile (14) by L2/M2 isolates have been reported [10] . Previously, indolyl-3-acetonitrile (14) was determined to be a phytoalexin in B. juncea but not in B. napus [3] .
Initially, the antifungal activities of phytoalexins 1, 6-13 and indolyl-3-acetonitrile (14) were determined using radial growth bioassays, as described in the Experimental. Among these phytoalexins only 6, 8 and 9 are produced in B. juncea. Results of these bioassays, as summarized in Table 1 , indicated that camalexin (13) , sinalexin (7) , and brassicanate A (12) were the best growth inhibitors of the phytoalexins tested. However, none of these phytoalexins appear to be produced in B. juncea.
Among the phytoalexins produced by B. juncea, brassilexin (6) displayed the strongest growth inhibitory activity against L. maculans isolates L2/M2 virulent on brown mustard.
Next, brassilexin (6) (t R = 11.1 min) was incubated with L2/M2 isolates and samples were withdrawn at different times, extracted and the extracts analyzed by HPLC ( Figure 1 ). Brassilexin (9) was rapidly metabolized to a more polar compound with a retention time of 6.2 min. This metabolite was identified as 3aminomethyleneindole-2-thione (15), which resulted from reduction of the N-S bond of the isothiazole ring. 3-Aminomethyleneindole-2-thione (15) was further metabolized to very polar metabolites, including 3-formylindolyl-2-sulfonic acid [11] . As previously established, 15 oxidized spontaneously to brassilexin (6) , but at a much slower rate than that of the enzymatic transformation. Sinalexin (7) (t R = 20.0 min) was metabolized to a more polar compound (t R = 12.3 min) identified as 1-methoxy-3-aminomethyleneindole-2-thione (16). In acidic media, this compound converted spontaneously to brassilexin (6) [11] , which in turn was transformed to 15. Interestingly, cyclobrassinin (8) (t R = 24.7 min) was also completely metabolized to 3-aminomethyleneindole-2-thione (15) (Scheme 2). Also, in this case, the enamine 15 was further transformed to more polar and less antifungal metabolites. Previously, it was discovered that isolates of L. maculans virulent on canola transformed cyclobrassinin (8) to the phytoalexin dioxibrassinin (11) , which was further transformed to non-toxic undetermined metabolites [4] .
(R,S)-Spirobrassinin (9) (t R = 10.1 min) and (R,S)-1methoxyspirobrassinin (10) (t R = 18.4 min) were metabolized by L2/M2 isolates to compounds 17 and 18, which were converted to more polar undetermined metabolites. To obtain larger amounts of compounds 17 and 18 for structure determination and bioassays, large-scale biotransformation experiments were carried out. After (9) at C-4′. The 13 C NMR spectrum showed the presence of a carbonyl at δ C 177.0, while a signal at δ C 199.5 indicated a thiocarbonyl. On the basis of this analysis, the structure was determined to be the spirothiazolidinethione 17 (Scheme 3, Figure  2 ). A recent patent on the preparation of indoleamine 2,3-dioxygenase inhibitors disclosed this compound, but no spectroscopic data have been published [12] . Similarly, spectroscopic analysis of the metabolite of 10 showed it to be identical to 1-methoxyspirothiazolidinethione 18, a compound previously isolated from the metabolism of 10 by S. sclerotiorum [13] (Scheme 3, Figure 2 ). The specific optical rotation values of compounds 17 and 18 ([α] D = -10 and -14, respectively) indicated that the enzymes involved in the metabolism of racemic 9 and 10 displayed some stereospecificity. Compounds 17 and 18 did not display growth inhibitory activity, hence these transformations are detoxifications. It is pertinent to note that neither spirobrassinin (9) nor 1-methoxyspirobrassinin (10) appeared to be detoxified by isolates of L. maculans virulent on canola [4] . (R,S)dioxibrassinin (11) was metabolized by L2/M2 to a more polar metabolite (t R = 4.8 min) over the course of five days. A larger scale experiment was carried out to obtain this metabolite in sufficient amount for characterization (0.8 mg). HRMS-EI analysis showed a [M] + peak at m/z 220.0313, which suggested the molecular formula C 10 H 8 N 2 O 2 S. The 1 H NMR spectrum of this metabolite revealed the typical protons of a 2oxoindole substituted at C-3, and two broad singlets at δ H 8.54 and 7.98. In addition, two diastereotopic protons at δ H 3.98 and 3.94 were observed, but no signals assignable to a methyl group were detected. The 13 C NMR spectrum revealed signals at δ C 188.4 and 173.2, which suggested the presence of thiocarbonyl and carbonyl carbons, respectively. On the basis of this data, the structure of the metabolite produced from (R,S)-dioxibrassinin (11) was proposed to be 19, and was confirmed by synthesis, as previously reported [14] . Compound 19 has not been reported as a natural product (Scheme 4). HPLC analysis of extracts of control flasks containing culture medium and 11 indicated that a small amount of 19 was also formed spontaneously after five days of incubation (corresponding to ca. 13±2% of dioxibrassinin (11) ). Brassicanate A (12) was transformed to the corresponding carboxylic acid, which was further transformed to more polar undetermined metabolites. Phytoalexins 1 and 7-13 were co-incubated with brassilexin (6) , in order to determine their effects on the rate of brassilexin (6) metabolism (Table S1 ). None of the phytoalexins seemed to affect substantially the rate of brassilexin metabolism. After 12 h of incubation, the amounts of brassilexin remaining in culture were as low as in controls, except in incubations with cyclobrassinin (8) and sinalexin (7) , which also resulted in the production of more brassilexin (6), as described above.
In summary, the biotransformations of spirobrassinins 9 and 10 to metabolites 17 and 18, respectively, is unusual in that the thiomethyl group was not hydrolyzed, a more common transformation previously observed in S. sclerotiorum [13] . Since both sulfur atoms remain in the scaffolds 17 and 18, it is likely that these transformations by isolates L2/M2 involved enzymatic oxidation of the S-methyl carbon.
Regardless of these unusual findings, our results indicate that isolates L2/M2 virulent on brown mustard detoxify brassilexin (6) , and other phytoalexins produced in brown mustard, quickly and that binary compositions of phytoalexins did not appear to slow down the rates of these detoxifications. L2/M2 isolates of L. maculans were not very sensitive to the phytoalexins produced in brown mustard, since only camalexin (13) , not produced in Brassica species [3] , appeared to have substantial inhibitory effect on the growth of the mycelium. These results suggest that the occurrence of these isolates in brown mustard growing areas has potential for causing significant yield losses. Therefore, it is of great importance to develop new B. juncea lines resistant to these fungal isolates, otherwise blackleg epidemics may occur within a short term.
Experimental
General: All chemicals were purchased from Sigma-Aldrich Canada Ltd., Oakville, ON; solvents were HPLC grade and used as such. Organic extracts were dried with Na 2 SO 4 and solvents removed under reduced pressure in a rotary evaporator. Flash column chromatography (FCC) was carried out using silica gel grade 60, mesh size 230 -400 Å and WP C 18 prepscale mesh size 275 Å. Preparative thin layer chromatography (prep TLC) was carried out on silica gel plates [Kieselgel 60 F 254 (20 × 20 cm × 0.25 mm)]; compounds were visualized under UV light.
Spectroscopy: Nuclear magnetic resonance (NMR) spectra ( 1 H, 13 C) were recorded on Bruker Avance 500 spectrometers. High resolution (HR) electron impact (EI) mass spectra (MS) were obtained on a VG 70 SE mass spectrometer, employing a solids probe. HPLC: HPLC analysis was carried out with Agilent high performance liquid chromatographs equipped with quaternary pump, automatic injector, and diode array detector (DAD, wavelength range 190 -600 nm), degasser, and a Hypersil ODS column (5 μm particle size silica, 4.6 i.d. x 200 mm), having an in-line filter. Mobile phase: 75% H 2 O -25% CH 3 CN to 100% CH 3 CN, for 35 min, linear gradient, and at a flow rate of 1.0 mL/min.
Fungal cultures for HPLC analysis: Liquid cultures of
Leptosphaeria maculans (isolates L2/M2) were grown in 100 mL Erlenmeyer flasks containing 50 mL of minimal medium [10] inoculated with fungal spores at 1×10 8 per flask. Cultures were incubated on a shaker at 120 rpm. After 48 h at 23 ± 1 o C, under constant light, a solution of brassilexin in CH 3 CN (250 µL) was added to the cultures, for a final phytoalexin concentration of 0.10 mM. The flasks were returned to the shaker, and samples (5 mL) were withdrawn at various times and either extracted immediately with ethyl acetate (2×10 mL) or immediately frozen to be extracted at a later time. The residue was then dissolved in CH 3 CN (500 μL) and analyzed by HPLC.
Co-incubation of phytoalexins with brassilexin (6):
Cultures were incubated in 50 mL of minimal media, as described above. After 48 h, a solution of the phytoalexin in CH 3 CN (200 µL) was added to the cultures to a concentration of 0.10 mM. The flasks were then returned to the shaker for 10 min. Brassilexin in CH 3 CN (200 µL) was added to the flasks, which were again returned to the shaker. Samples (5 mL) were withdrawn at various times, and either immediately extracted with ethyl acetate (2 x 10 mL) or immediately frozen and extracted at a later time. The residue was then dissolved in CH 3 CN (500 μL) and analyzed by HPLC.
Radial growth bioassays: L2/M2 spores were spotted onto V8 agar plates and allowed to grow for 7 days under constant light at 23 ± 1 o C. Plugs (6 mm) were cut from the edges of the mycelia and placed inverted onto six-well plates containing phytoalexins in DMSO mixed into potato dextrose agar. The final concentrations of each phytoalexin in agar were 0.1, 0.2, or 0.5 mM, with a DMSO concentration of 1%. The plates were allowed to grow under constant light at 23 ± 1 o C for 5 days, after which the diameter of the mycelial mat was measured and compared with control mycelia grown on plates containing DMSO only.
Synthesis of phytoalexins:
Phytoalexins used in all experiments were synthesized as previously reported [3] . 
-M e t h o x y -2 ' -t h i o x o s p i r o [ 3 H -i n d o l e -3 , 5 'thiazolidin]-2(1H)-one (18)
HPLC: t R = 13.1 min.
[α] D :-14 (c 0.16, MeOH). Spectral data identical to previously published data [13] . Table S1 . Concentrations of brassilexin (6) in cultures of Leptosphaeria maculans, isolates L2/M2 virulent on brown mustard co-incubated with phytoalexins 1, 7-13 and indole-3-acetonitrile (14) .
Spiro[indoline-3,5'-oxazolidin]-2-one-2'-thione
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